Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymocyte nuclear protein 1 is a highly conserved nuclear protein encoded by the *THYN1* gene in humans and is present across vertebrate and plant species[1][2][3][7]. It is implicated in the induction of apoptosis, particularly in lymphocytes, and may play a role in modulating cell survival versus programmed cell death[1][2][3]. THYN1 possesses a unique DUF55 domain with structural similarity to RNA-binding modules such as the YTH domain, supporting a possible function in nucleic acid binding and post-transcriptional gene regulation[2]. Its precise cellular roles remain to be fully elucidated, but it is proposed to integrate apoptotic signals during immune cell development[2]. The protein primarily localizes to the nucleus and shows expression across multiple tissues, especially lymphoid organs[3]. Currently, there are no specific drugs or established disease associations, and it is not considered a standard therapeutic target[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymocyte nuclear protein 1 (THYN1).